抗体疗法有望改变对婴儿呼吸道合胞病毒的预防。 - Suppr

Antibody therapies set to transform respiratory syncytial virus prevention for babies.

作者信息

Dolgin Elie

出版信息

Nature. 2023 Sep;621(7980):S55-S57. doi: 10.1038/d41586-023-02957-z.

DOI:10.1038/d41586-023-02957-z

PMID:37758887

Abstract

摘要

相似文献

Antibody therapies set to transform respiratory syncytial virus prevention for babies.

Nature. 2023 Sep;621(7980):S55-S57. doi: 10.1038/d41586-023-02957-z.

Respiratory syncytial virus in infants: is maternal vaccination a realistic strategy?

Curr Opin Infect Dis. 2015 Jun;28(3):221-4. doi: 10.1097/QCO.0000000000000161.

Pharmacologic advances in the treatment and prevention of respiratory syncytial virus.

Clin Infect Dis. 2010 May 1;50(9):1258-67. doi: 10.1086/651603.

Investigational RSV Vaccine Given During Pregnancy Protects Newborns.

JAMA. 2022 Dec 13;328(22):2201. doi: 10.1001/jama.2022.20032.

Preventing Pediatric Respiratory Syncytial Virus Infection.

Pediatr Ann. 2018 Sep 1;47(9):e371-e376. doi: 10.3928/19382359-20180816-01.

Respiratory syncytial virus infections: recent prospects for control.

Antiviral Res. 2006 Sep;71(2-3):379-90. doi: 10.1016/j.antiviral.2006.05.014. Epub 2006 Jun 9.

Group B streptococcus and respiratory syncytial virus immunisation during pregnancy: a landscape analysis.

Lancet Infect Dis. 2017 Jul;17(7):e223-e234. doi: 10.1016/S1473-3099(17)30232-3. Epub 2017 Apr 19.

The mouse model of respiratory syncytial virus disease.

Curr Top Microbiol Immunol. 2013;372:359-69. doi: 10.1007/978-3-642-38919-1_18.

The cotton rat Sigmodon hispidus model of respiratory syncytial virus infection.

Curr Top Microbiol Immunol. 2013;372:347-58. doi: 10.1007/978-3-642-38919-1_17.

Safety and Immunogenicity of the Respiratory Syncytial Virus Vaccine RSV/ΔNS2/Δ1313/I1314L in RSV-Seronegative Children.

J Infect Dis. 2020 Jun 16;222(1):82-91. doi: 10.1093/infdis/jiz408.

引用本文的文献

Expert consensus on the diagnosis, treatment, and prevention of respiratory syncytial virus infections in children.

World J Pediatr. 2024 Jan;20(1):11-25. doi: 10.1007/s12519-023-00777-9. Epub 2023 Dec 8.

本文引用的文献

New Interventions to Prevent Respiratory Syncytial Virus Disease in Infants-Time for Equitable Global Access.

Am J Respir Crit Care Med. 2023 Jun 15;207(12):1556-1557. doi: 10.1164/rccm.202303-0568VP.

Durability of neutralizing RSV antibodies following nirsevimab administration and elicitation of the natural immune response to RSV infection in infants.

Nat Med. 2023 May;29(5):1172-1179. doi: 10.1038/s41591-023-02316-5. Epub 2023 Apr 24.

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.

N Engl J Med. 2023 Apr 20;388(16):1451-1464. doi: 10.1056/NEJMoa2216480. Epub 2023 Apr 5.

Nirsevimab for Prevention of RSV in Term and Late-Preterm Infants.

N Engl J Med. 2023 Apr 20;388(16):1533-1534. doi: 10.1056/NEJMc2214773. Epub 2023 Apr 5.

Nirsevimab binding-site conservation in respiratory syncytial virus fusion glycoprotein worldwide between 1956 and 2021: an analysis of observational study sequencing data.

Lancet Infect Dis. 2023 Jul;23(7):856-866. doi: 10.1016/S1473-3099(23)00062-2. Epub 2023 Mar 17.

Expected Impact of Universal Immunization With Nirsevimab Against RSV-Related Outcomes and Costs Among All US Infants in Their First RSV Season: A Static Model.

J Infect Dis. 2022 Aug 15;226(Suppl 2):S282-S292. doi: 10.1093/infdis/jiac216.

Nirsevimab for Prevention of RSV in Healthy Late-Preterm and Term Infants.

N Engl J Med. 2022 Mar 3;386(9):837-846. doi: 10.1056/NEJMoa2110275.

Effectiveness and cost-effectiveness of RSV infant and maternal immunization programs: A case study of Nunavik, Canada.

EClinicalMedicine. 2021 Sep 24;41:101141. doi: 10.1016/j.eclinm.2021.101141. eCollection 2021 Nov.

Global Molecular Epidemiology of Respiratory Syncytial Virus from the 2017-2018 INFORM-RSV Study.

J Clin Microbiol. 2020 Dec 17;59(1). doi: 10.1128/JCM.01828-20.

Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants.

Clin Infect Dis. 2021 Dec 6;73(11):e4400-e4408. doi: 10.1093/cid/ciaa951.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Antibody therapies set to transform respiratory syncytial virus prevention for babies.

作者信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献